Title : Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models.

Pub. Date : 2021 May 27

PMID : 34045483






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lapatinib (L) plus trastuzumab (T), with endocrine therapy for estrogen receptor (ER)+ tumors, but without chemotherapy, yielded meaningful response in HER2+ breast cancer (BC) neoadjuvant trials. Lapatinib erb-b2 receptor tyrosine kinase 2 Homo sapiens